公司資料
Eagle Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- EGRX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.96 USD (+1.05%)
收盤價
最後更新: 2026年10月1日
—
市值
股價為何變動
截至 2026年10月1日，EGRX 上漲 1.05%，收於 $0.9600。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on hospital and acute-care products. Its business has historically centered on commercialization of focused injectable or hospital-based medicines.
所在地與產業分類
Eagle is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and hospital care.
商業模式特徵
The company depends on product sales, hospital access, and portfolio management. Investors usually watch revenue, execution, and strategic changes.
生技產業定位
Eagle occupies a hospital-specialty niche within pharma. It is more commercial than development-stage biotech and tends to respond to product and portfolio developments.
未來催化劑
- Eagle’s catalysts are hospital-product execution and any portfolio update that clarifies the company’s growth path. The market cares about recurring demand and margin discipline.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。